Lion Biotechnologies - 48 Year Dividend Yield History | IOVA

Historical dividend payout and yield for Lion Biotechnologies (IOVA) since 1971. The current TTM dividend payout for Lion Biotechnologies (IOVA) as of February 15, 2019 is $0.00. The current dividend yield for Lion Biotechnologies as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.272B $0.000B
Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies Inc., is based in SAN CARLOS, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76